Hemal Mehta
@mehtahemal
Followers
179
Following
655
Statuses
288
Associate Professor @JohnsHopkinsEPI | Pharmacoepidemiology
Baltimore, MD
Joined March 2010
0
0
0
RT @AnnalsofIM: New from @JohnsHopkinsSPH @mehtahemal: #S-Elixhauser is well calibrated and internally validated but advantage over the #AH…
0
1
0
RT @UTMB_SCOA: During the SARS-CoV-2 pandemic, we found prolonged increases in mortality rates after hospitalization for non-SARS-CoV-2 ill…
0
2
0
RT @JAMANetworkOpen: During the #COVID19 pandemic, this cohort study found prolonged increases in mortality rates after hospitalization for…
0
5
0
RT @JohnsHopkinsSPH: "This is my body, I have to defend it!" 🏠 Reminder: Being vaccinated and boosted is your best line of defense against…
0
13K
0
@Rishidesai11 @MichaelEMatheny @kbjohnsonmd @lmhcurtis @darrentoh_epi Important work and nicely presented. Congratulations!
0
0
2
RT @TheLancetRheum: NEW RESEARCH—Long-term use of immunosuppressive medicines and in-hospital #COVID19 outcomes: data from N3C shows no inc…
0
23
0
RT @HopkinsMedNews: .@Hopkins_GIM expert and @JohnsHopkinsSPH experts find #drug increases #risk for #death in older adults with #Parkinson…
0
4
0
RT @JohnsHopkinsSPH: “These findings underscore the wide variation in COVID-19 care across American health systems,” says study lead author…
0
9
0
A BIG thanks to the N3C pharmacoepi team for the amazing team effort and all the people who help build the #N3C
0
0
0